This website uses cookies to ensure you get the best experience on our website. Learn more

NEW Rapid Antigen Test for COVID 19 (Quick, Cheap, and Reliable) | Rapid Test COVID 19

x

NEW Rapid Antigen Test for COVID 19 (Quick, Cheap, and Reliable) | Rapid Test COVID 19

NEW Rapid Antigen Test for COVID 19 (Quick, Cheap, and Reliable) | Rapid Test COVID 19

Coronavirus | COVID-19 YouTube Video Playlist:


So there has been some big news when it comes to coronavirus testing. Recently, Abbott Laboratories came out with a new rapid antigen test called BinaxNOW COVID-19 Ag Card, and it got emergency approval from the Food and Drug Administration (FDA). An Emergency use authorization by the FDA is permission given to unapproved products to be used in an emergency to diagnose, treat, or prevent serious or life-threatening conditions.

Link to FDA website for this test:


The rapid test covid 19test costs $5 and detects COVID-19 infection in 15 minutes. This new BinaxNOW rapid antigen test made by Abbott Laboratories uses a nasal swab in the same manner as a rapid flu test. Unlike most of the other nasal swabs used to test COVID, this one doesn’t have to be jammed all the way up in the nose. According to Abbott, and this is listed on the FDA’s website, the test has demonstrated 97.1% sensitivity and 98.5% specificity. These tests are compared to samples that tested positive with the PCR method, and they then compare the results. Also, I should mention that the NIH does independent tests to verify the accuracy of coronavirus tests because its hard to trust a company’s own numbers. But these are the numbers that the company is claiming, and so far there aren’t independent tests that have been done. The FDA said in a statement that negative results with Abbott's test may need to be confirmed with a lab test in some cases. For example, if there is a high suspicion that someone has COVID based on their symptoms or exposure.

Also, I should add, that even if a test is perfect, let's say in theory its 100% sensitive and 100% specific, it's still possible to get a false negative – not because of the test itself. Sometimes its due to the way the test is conducted, meaning poor technique is used. Sometimes, when it comes to coronavirus - some people can have the coronavirus in their lungs, without necessarily having it in their nose. This was actually proven, and I did a video on this, in a study of patients who died of coronavirus. 9 out of the 12 patients had the virus in their lungs but not their nose, and they used PCR testing for this. So that’s something else to keep in mind.

Another aspect of this BinaxNOW test is that it will come with a free mobile app called NOVICA, which will allow users that test negative to display their results as a digital health pass, This digital health pass would serve as a temporary, date-stamped result that is renewed each time a new test is taken. With the typical PCR tests that are done, meaning the ones that are lab-based, you get excellent sensitivity but they take time, a least a few hours or longer to get results. Since the start of the pandemic, nasal swab tests that are sent to a lab have been the standard for COVID-19 screening. While these PCR tests are considered the most accurate, they take at minimum a few hours before you get results. They’re also expensive and require specialized machines and chemical reagents, and shortages of these supplies have led to delays in getting results. But with this new antigen test, we can quickly identify COVID infections and get them into quarantine. Plus, it’s cheap, and is being massed produced…Abbott says that starting October they will ship 50 million tests a month. And following this announcement, the government said they will be purchasing 150 million of these tests from the company. This will allow for massive testing, moving one step closer to getting this pandemic under control, especially when it comes to getting schools and businesses reopened, and especially with the fall and winter coming, which means cold and flu season. And with such an overlap of symptoms between the common cold, flu, and COVID, this massive scale rapid testing will be all the more important. With this test, along with the other 3 FDA approved rapid antigen tests, they can’t be done at home, as they’re only allowed to be given by healthcare professionals. So basically, doctor's offices, emergency rooms, urgent care centers, pharmacies, drive-thrus, and some schools.

Dr. Mike Hansen, MD
Internal Medicine | Pulmonary Disease | Critical Care Medicine
Website:
Instagram Account:

#coronavirus #covid19 #covid_19
x

Describing antigen testing for COVID 19

Antigen testing offers a cheaper and faster method of diagnosing COVID-19 compared to RT-PCR–but it comes with a significant limitation. In this video from our COVID Mini: Diagnostics course, we look into how this test works and consider the benefits and drawbacks of integrating it into the COVID-19 diagnostic process.

Continue your understanding of this deadly disease through our COVID Mini: Diagnostics course.

Check out our course library and register for a free trial account:

Please Note: Medmastery's videos, medical lectures, medical illustrations, and medical animations are for medical education and exam preparation purposes, and not intended to replace recommendations by your doctor or health care provider.

#medmastery #coronavirus #COVID19 #sarscov2 #coronaviruschina #coronavirustruth #WHO #wuhan #infection #pandemic #publichealth
x

Coronavirus rapid antigen testing: Major step forward or false hope? | COVID-19 Special

A strong testing regime plays a key role in slowing the spread of COVID-19. But getting tested can be a major challenge. Several nations are developing rapid tests, that turn out results within minutes. In Germany the new antigen test is on the market now – it is not an antibody test or a regular lab test – it checks for the virus in people’s saliva and promises a result within 15 minutes, without a laboratory or doctor involved. But experts are concerned about their accuracy. How user friendly is the test and is it reliable? 

Subscribe:

For more news go to:
Follow DW on social media:
►Facebook:
►Twitter:
►Instagram:
Für Videos in deutscher Sprache besuchen Sie:
#Coronavirus #AntigenTest #RapidTesting
x

False Positives - COVID 19 Rapid Tests - Questions for Dr. Mina

Harvard professor and epidemiologist Dr. Michael Mina responds to the idea that that inexpensive paper strip tests would produce too many false positives to be useful as a screening tool to curb the pandemic. False positives occur when someone tests positive but is not infected with SARS-CoV-2 that causes COVID-19.

See our previous MedCram videos that have featured Dr. Mina's research about COVID 19 testing and how quickly identifying individuals who are contagious (and who have high levels of SARS-CoV-2 virus) should be the primary focus.

Dr. Mina, Kyle Allred, Dr. Seheult, and MedCram have no financial disclosures related to this topic. We have a keen interest in curbing this pandemic and safely re-opening schools and our economy.

Michael Mina, MD Ph.D. is an Assistant Professor of Epidemiology, Immunology, and Infectious Diseases at Harvard T. H. Chan School of Public Health. Dr. Mina is also a core member of the Center for Communicable Disease Dynamics (CCDD) and an Associate Medical Director in Clinical Microbiology. Dr. Mina's bio is here:

MORE VIDEOS AND RESOURCES ON AT-HOME COVID 19 SCREENING TESTS:

Dr. Mina is the director (on a volunteer basis) of where you can get more info and streamlined ways to contact your governor and representatives in Congress about at-home COVID 19 screening

A 3-minute explainer video on inexpensive at-home rapid screening tests by MedCram:

A video summary and highlights of Dr. Mina's research and ideas in our MedCram COVID 19 Update 98:

A 5 minute summary with Dr. Mina of some key differences between COVID-19 antigen tests with rapid results:

A short explainer video on daily quick tests produced by Dr. Allen:

Summary Article Featured in the Atlantic about Inexpensive Rapid Testing:

Dr. Mina's research paper: Test sensitivity is secondary to frequency and turnaround time for COVID-19 surveillance (Pre-print)

TWiV 640: Test often, fast turnaround, interview with Michael Mina:


------------------------------------------------------
Video produced by Kyle Allred, Co-Founder of
Contact Kyle or MedCram by emailing: customers@medcram.com

#COVID19 #rapidtestsnow #dailyquicktest
x

COVID 19 Antigen Testing At Home: Would It Be Too Expensive?

Harvard professor and epidemiologist Michael Mina, MD, PhD, explains the relative cost of frequent, at-home COVID-19 testing (using inexpensive paper strip antigen tests) to allow schools and businesses to re-open.

Michael Mina, MD Ph.D. is an Assistant Professor of Epidemiology, Immunology, and Infectious Diseases at Harvard T. H. Chan School of Public Health. Dr. Mina is also a core member of the Center for Communicable Disease Dynamics (CCDD) and an Associate Medical Director in Clinical Microbiology. Dr. Mina's bio is here:

We have no financial disclosures related to any medical products. MedCram has a strong interest in curbing this pandemic and safely re-opening schools and our economy, and we believe Dr. Mina's approach to testing could be effective - especially compared to the current testing approach in the United States.

Other Q/A videos with Dr. Michael Mina on inexpensive quick paper antigen tests for COVID-19:

Paper Strip Tests for COVID-19: Should We Wait Until They Rival PCR Tests?

Are Antigen Paper Tests for COVID 19 Accurate Enough?

False Positives and COVID 19 Rapid Tests:

What if Some Don't Cooperate with COVID 19 Rapid Testing (Herd Immunity and Effects)?


MORE VIDEOS AND RESOURCES ON AT-HOME COVID 19 SCREENING TESTS:

Dr. Michael Mina is the director (on a volunteer basis) of where you can get more info and streamlined ways to contact your governor and representatives in Congress about at-home COVID 19 screening

See our previous MedCram videos that have featured Dr. Mina's research about COVID 19 testing and how quickly identifying individuals who are contagious (and who have high levels of SARS-CoV-2 virus) should be the primary focus.

A 3-minute explainer video on inexpensive at-home rapid screening tests by MedCram:

A video summary and highlights of Dr. Mina's research and ideas in our MedCram COVID 19 Update 98:

A 5 minute summary with Dr. Mina of some key differences between COVID-19 antigen tests with rapid results:

A short explainer video on daily quick tests produced by Dr. Allen:

Summary Article Featured in the Atlantic about Inexpensive Rapid Testing:

Dr. Mina's research paper: Test sensitivity is secondary to frequency and turnaround time for COVID-19 surveillance (Pre-print)

TWiV 640: Test often, fast turnaround, interview with Michael Mina:

Visit MedCram.com for over 100 coronavirus pandemic updates including sensitivity vs specificity, covid 19 tests, diagnosis and treatment, and many more topics.

------------------------------------------------------
Video produced by Kyle Allred, Co-Founder of
Contact Kyle or MedCram by emailing: customers@medcram.com

#COVID19 #rapidtestsnow #dailyquicktest

How Covid 19 rapid detection kit (Antibody kit) works?

Antibody-based rapid detection kit for novel coronavirus.

COVID-19 IgM/IgG Rapid Test

Product Page:

This is an instructional video for the RayBiotech Coronavirus (COVID-19) IgM/IgG Rapid Test for medical professionals and laboratories only.

COVID-19 Rapid Tests Demo & Q/A with E25Bio Co-Founder Dr. Herrera (Antigen Daily Quick Tests)

Simple and cheap COVID-19 tests that provide rapid results (15 min.) have been called a possible game-changer to curb the pandemic and allow schools and stores to open safely. Our guest today is Bobby Brooke Herrera, Ph.D. - the Co-Founder of a small company based in Massachusetts called E25Bio. Back on February 26, 2020, E25Bio had its inexpensive COVID-19 antigen test developed, but his company has run into numerous hurdles - lack of guidance and reasonable standards from the FDA, limited federal investment into public health testing strategies, and challenging pathways to production and distribution.

Dr. Herrera gives a demo of their simple test that requires a simple nasal swab, plastic tube, a paper strip, and no additional processing. He also discusses how tests like this could be distributed and utilized to quickly curtail the spread of COVID-19. (This video was recorded August 12, 2020).

LINKS / REFERENCES:

More about Dr. Bobby Brooke Herrera - Co-Founder of E25Bio |

MedCram Update 98 for context on rapid daily quick tests and Dr. Mina's research |

5-Minute Sharable Video About At-Home Rapid Tests |

Boston Globe Article about E25Bio |

THE MEDCRAM WEBSITE:

Visit us for videos on over 60 medical topics and CME / CEs for medical professionals:


SUBSCRIBE TO THE MEDCRAM YOUTUBE CHANNEL:


Get notified of new videos by hitting the bell icon:


PREVIOUS COVID-19 UPDATES:

Please visit MedCram.com for the full series:
- COVID-19 Pandemic Update 101: T Cell Immunity vs. Antibodies & Prior Exposure to Other Coronaviruses
- At Home, Cheap, COVID-19 Tests with Results in 15 Minutes: How to Fix Testing with Dr. Michael Mina
- Coronavirus Pandemic Update 100: Interferon Beta COVID-19 Treatment, and a Retrospective
- Coronavirus Pandemic Update 99: Long Haulers - Lingering & Long-Term Symptoms After COVID-19
- Coronavirus Pandemic Update 98: At Home COVID-19 Testing - A Possible Breakthrough
- Coronavirus Pandemic Update 97: Vitamin D & COVID-19 Immunity, The Endothelium, & Deficiencies
- Coronavirus Pandemic Update 96: RNA Vaccine; Ivermectin; von Willebrand Factor and COVID-19
- Coronavirus Pandemic Update 95: Widespread Clotting on Autopsy; New COVID-19 Prognostic Data
- Coronavirus Pandemic Update 94: Inhaled Steroids COVID-19 Treatment; New Pneumonia in Kazakhstan?
- Coronavirus Pandemic Update 93: Antibodies, Immunity, & Prevalence of COVID-19 - New Data from Spain
- Coronavirus Pandemic Update 92: Blood Clots & COVID-19 - New Research & Potential Role of NAC
- Coronavirus Pandemic Update 91: Remdesivir Pricing & Disparities in Drug Availability

All coronavirus updates are at MedCram.com (including more on vaccine developments, rapid COVID-19 testing, paper COVID 19 antigen tests, COVID 19 antibody tests, coronavirus daily quick tests, coronavirus news, COVID test, peer-reviewed research, and more).
We offer many other medical topics (ECG Interpretation, asthma, acute kidney injury, pulmonary embolism, myocardial infarction, hypertension, DKA, influenza, measles, mechanical ventilation, etc.) at our website.


MEDCRAM WORKS WITH MEDICAL PROGRAMS AND HOSPITALS:

MedCram offers group discounts for students and a variety of medical programs, hospitals, and other institutions. We also offer over 40 hours of CME and CEU credits. Contact us at customers@medcram.com if you are interested.


MEDIA CONTACT:

Media Contact: customers@medcram.com
Media contact info:

Video Produced by Kyle Allred


FOLLOW US ON SOCIAL MEDIA:






DISCLAIMER:

MedCram medical videos are for medical education and exam preparation, and NOT intended to replace recommendations from your doctor.
#COVID19 #RapidTestsNow #DailyQuickTest

We test a home antibody kit for tracking Covid-19 transmission

Home testing kits will likely be an important part of monitoring Covid-19. Swab tests can tell whether a person is currently infected, while antibody tests look for signs of past infection. But before tests like these are rolled out, researchers need to make sure they're reliable and easy for people to use at home. We gave one of the home testing kits a go, and spoke to researcher Christina Atchison about the REACT (real-time assessment of community transmission) study being run by Imperial College London in the UK.

Read more coronavirus news at nature.com and sign up for the Nature Briefing: An essential round-up of science news, opinion and analysis, free in your inbox every weekday:

COVID-19 IgM/IgG Rapid Test Kit

this video shows how to use COVID-19 IgM/IgG Rapid Test Kit. This is not for home use. Check more info on
x

Coronavirus rapid test: FDA approves Abbott rapid COVID-19 antigen test

Dr. Darria Long, ER Physician and Clinical Assistant Professor at University of Tennessee School of Medicine, joins Yahoo Finance’s Zack Guzman to discuss the latest developments in rapid COVID-19 testing from Abbott.
#coronavirus #COVID19 #antigentest
Subscribe to Yahoo Finance:

About Yahoo Finance:
At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

Connect with Yahoo Finance:
Get the latest news:
Find Yahoo Finance on Facebook:
Follow Yahoo Finance on Twitter:
Follow Yahoo Finance on Instagram:
Follow Cashay.com

Rapid COVID-19 antigen test approved by Health Canada

In an effort to reduce a testing backlog, Health Canada has approved a rapid antigen test for COVID-19 that produces results in less than 20 minutes. The federal government has ordered more than 20 million of the tests, but they’re believed to be less accurate than others.

Watch The National live on YouTube Sunday-Friday at 9 p.m. ET

Subscribe to The National:


Connect with The National online:
Facebook |
Twitter |
Instagram |

More from CBC News |

The National is CBC's flagship nightly news program, featuring the day's top stories with in-depth and original journalism, with hosts Adrienne Arsenault and Andrew Chang in Toronto, Ian Hanomansing in Vancouver and the CBC's chief political correspondent, Rosemary Barton in Ottawa.

Coronavirus:FDA approves $5 rapid COVID-19 antigen test for emergency use authorization from Abbott

Dr. Soren Christiansen, former Head of Vaccines at Merck and CEO of Sharps Technology, joined The Final Round to discuss the latest developments regarding a COVID-19 vaccine and his thoughts on the FDA approving Abbott's rapid coronavirus test.
#coronavirustest #COVID19testing #rapidcoronavirustesting
Video Transcript
SEANA SMITH: Let's get to another big story of the day. We talk about all these factors that are influencing the market. One, we had the Fed, but then we also had this big announcement out from Abbott. And we saw the reaction in Abbot's shares today, the stock up almost 8% on this news. Now, the news coming that Abbott has now gained FDA authorization for a $5 rapid coronavirus test.

Now, here to talk a little bit more about this and also finding a COVID-19 vaccine, I want to bring in Dr. Soren Christiansen, former Head of Vaccines at Merck. He's now the CEO of Sharps Technology. And we also have Yahoo Finance's Anjalee Khemlani joining the conversation.

And Dr. Christiansen, let's just talk about this test, I mean, the fact that it can produce results in 15 minutes. It doesn't require lab equipment. Abbott saying that it's going to be able to produce 50 million a month by October. How big of a game changer is this?

SOREN CHRISTIANSEN: Yeah, to me this is really a game changer. So you pointed out a couple of points with this test. So access should not be a problem. They have promised to manufacture 50 million per months.

Timing should not be a problem. And I would add that the accuracy of the test, as far as I've been watching, is 98%. So it's very reliable. So when you get the results, you can basically trust that you are positive or you are negative. So this is really fantastic to me.

For more on this transcript please click:


Subscribe to Yahoo Finance:

About Yahoo Finance:
At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

Connect with Yahoo Finance:
Get the latest news:
Find Yahoo Finance on Facebook:
Follow Yahoo Finance on Twitter:
Follow Yahoo Finance on Instagram:
Follow Cashay.com

NADAL® COVID-19 Ag Test - COVID-19 Antigen Rapid Test

The NADAL® COVID-19 Antigen Rapid Test is a lateral flow chromatographic immunoassay for the qualitative detection of SARS-CoV-2 viral nucleoprotein antigens in human nasopharyngeal and oropharyngeal specimens.
The NADAL® COVID-19 Antigen Rapid Test detects the virus directly by looking for the presence of SARS-CoV-2 specific proteins. Fast and reliable test results in just 15 minutes with high specificity of more than 99.9 % and a sensitivity of 97.56% at a Ct-value 20-30.

NOTE: The NADAL® COVID-19 Ag rapid tests is approved for professional users (i.e. medical personnel) only.

© nal von minden GmbH |

Are rapid response COVID-19 tests accurate?

The governor says ALL travelers or residents coming into Mass from basically every state, except those in New England, New York and New Jersey must have a negative COVID-19 test and fill out a questionnaire.

Subscribe to WCVB on YouTube now for more:

Get more Boston news:
Like us:
Follow us:
Instagram:
x

Self Testing for COVID 19 with Rapid Antigen Tests: Dr. Mina Q/A

Harvard professor and epidemiologist Michael Mina, MD, Ph.D has been a strong advocate for inexpensive paper strip COVID-19 antigen tests (that provide rapid results in 15 minutes) that he believes are sensitive and accurate enough to turn positive for the vast majority of contagious COVID-19 infections.

In this video, Dr. Mina challenges the notion that individuals need medical professionals to administer COVID-19 tests and directly give information about results. And how in the past, home pregnancy tests were considered too risky for women to utilize.

Dr. Mina is an Assistant Professor of Epidemiology, Immunology, and Infectious Diseases at Harvard T. H. Chan School of Public Health. Dr. Mina is also a core member of the Center for Communicable Disease Dynamics (CCDD) and an Associate Medical Director in Clinical Microbiology. Dr. Mina's bio is here:

We have no financial disclosures related to any medical products. MedCram has a strong interest in curbing this pandemic and safely re-opening schools and our economy, and we believe Dr. Mina's approach to testing could be effective - especially compared to the current testing approach in the United States.

OTHER Q/A VIDEOS WITH DR. MICHAEL MINA:

Paper Strip Tests for COVID-19: Should We Wait Until They Rival PCR Tests?

Are Antigen Paper Tests for COVID 19 Accurate Enough?

False Positives and COVID 19 Rapid Tests:

What if Some Don't Cooperate with COVID 19 Rapid Testing (Herd Immunity and Effects)?

Would Widespread COVID 19 Antigen Testing At Home Be Too Expensive?


MORE VIDEOS AND RESOURCES ON AT-HOME COVID 19 SCREENING TESTS:

Dr. Michael Mina is the director (on a volunteer basis) of where you can get more info and streamlined ways to contact your governor and representatives in Congress about at-home COVID 19 screening

See our previous MedCram videos that have featured Dr. Mina's research about COVID 19 testing and how quickly identifying individuals who are contagious (and who have high levels of SARS-CoV-2 virus) should be the primary focus.

A 3-minute explainer video on inexpensive at-home rapid screening tests by MedCram:

A video summary and highlights of Dr. Mina's research and ideas in our MedCram COVID 19 Update 98:

A 5 minute summary with Dr. Mina of some key differences between COVID-19 antigen tests with rapid results:

A short explainer video on daily quick tests produced by Dr. Allen:

Summary Article Featured in the Atlantic about Inexpensive Rapid Testing:

Dr. Mina's research paper: Test sensitivity is secondary to frequency and turnaround time for COVID-19 surveillance (Pre-print)

TWiV 640: Test often, fast turnaround, interview with Michael Mina:

Visit MedCram.com for over 100 coronavirus pandemic updates including sensitivity vs specificity, COVID 19 tests, diagnosis and treatment, and many more topics.

------------------------------------------------------
Video produced by Kyle Allred, Co-Founder of
Contact Kyle or MedCram by emailing: customers@medcram.com

#COVID19 #rapidtestsnow #dailyquicktest

Bioeasy COVID-19 Ag Rapid Test (Fluorescence Immunochromatographic Assay)

BIOEASY 2019-nCoV Ag Fluorescence Test is a fast and reliable test for 2019-nCoV. With the addition of deep sputum or nasal swab, it can result in 10 minutes by simple operation.
For more product details, please contact info@bioeasy.com.

Coronavirus antigen test: 3M and MIT look to develop a low cost, accurate, and rapid COVID-19 test

John Banovetz 3M SVP of Innovation and Stewardship and CTO joins the On the Move panel and Yahoo Finance’s Anjalee Khemlani to discuss 3M’s partnership with MIT in developing a coronavirus antigen test.
#covid19 #coronavirus #COVID19antigentest

Subscribe to Yahoo Finance:

About Yahoo Finance:
At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

Connect with Yahoo Finance:
Get the latest news:
Find Yahoo Finance on Facebook:
Follow Yahoo Finance on Twitter:
Follow Yahoo Finance on Instagram:

Concerns about current use of rapid antigen tests for COVID-19

The 15-minute antigen test can be processed on-site, making it a growing choice for people who are looking for results in less than a week.

Subscribe to WCVB on YouTube now for more:

Get more Boston news:
Like us:
Follow us:
Instagram:

FDA approves first antigen test to detect the coronavirus that provides results in minutes

The Food and Drug Administration has granted emergency authorization for a new antigen test to detect the coronavirus that could be cheaper, faster and simpler. Dr. David Agus explained on CBS This Morning what the test looks for and how it can provide results in just minutes.

Shares

x

Check Also

x

Menu